Aldaas Omar M, Ma Gary, Bui Quan, Reeves Ryan R, Birgersdotter-Green Ulrika
Division of Cardiology, University of California San Diego, La Jolla, California.
Struct Heart. 2024 May 22;9(1):100319. doi: 10.1016/j.shj.2024.100319. eCollection 2025 Jan.
Cardiac implantable electronic devices (CIEDs) have been increasingly used in the management of various rhythm disorders amidst an aging population with more prevalent cardiovascular comorbidities. Although generally well-tolerated and safe, implantation of CIEDs may result in or worsen tricuspid regurgitation (TR), which is associated with a higher risk of morbidity and mortality. Several mechanisms of TR following device implantation have been proposed, and multiple diagnostic tests, percutaneous and surgical interventions, and alternative pacing methods have been developed to address this. CIED-related TR thus requires a multidisciplinary team of experts in cardiac imaging, interventional cardiology, electrophysiology, and cardiothoracic surgery with a comprehensive understanding of this multifaceted disease. The objective of this review is to summarize the epidemiology, clinical presentation, and management of CIED-related TR.
在心血管合并症更为普遍的老龄化人群中，心脏植入式电子设备（CIED）越来越多地用于各种心律失常的管理。尽管CIED植入通常耐受性良好且安全，但仍可能导致三尖瓣反流（TR）或使其恶化，而TR与更高的发病率和死亡率风险相关。已经提出了设备植入后TR的几种机制，并且已经开发了多种诊断测试、经皮和外科干预措施以及替代起搏方法来解决这一问题。因此，与CIED相关的TR需要一个由心脏成像、介入心脏病学、电生理学和心胸外科专家组成的多学科团队，他们要对这种多方面的疾病有全面的了解。本综述的目的是总结与CIED相关的TR的流行病学、临床表现和管理。
